Small cells lung epidermoid carcinoma in a HTLV1-infected patient: case report and literature review

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
INST MEDICINA TROPICAL SAO PAULO
Autores
DAHY, Flavia Esper
PALHARES, Renata Basic
SMID, Jerusa
MOURA, Joao Victor Luisi de
HAZIOT, Michel E. J.
MARCUSSO, Rosa Maria N.
OLIVEIRA, Augusto Cesar Penalva de
Citação
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.63, article ID e35, 5p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The human T cell lymphotropic virus type 1 (HTLV-1) is the first human retrovirus discovered. Since then, it has spread worldwide and is mainly associated with adult T cell leukemia/lymphoma (ATLL) and HTLV1-associated myelopathy (HAM). Its relationship, however, with other types of cancer is controversial. We describe the case of a patient presenting with small cells lung epidermoid carcinoma who had recently developed HAM, and a review of the literature related to these conditions. This is the first case of this type of lung cancer, the same of the first description in the literature, associated with HAM outside Japan.
Palavras-chave
HTLV-1, ATLL, Cancer, Neoplasia, Oncogenesis
Referências
  1. ABO T, 1983, J IMMUNOL, V131, P1822
  2. Arisawa K, 2003, CANCER CAUSE CONTROL, V14, P889, DOI 10.1023/B:CACO.0000003853.82298.96
  3. Arisawa K, 2006, CANCER SCI, V97, P535, DOI 10.1111/j.1349-7006.2006.00212.x
  4. ASOU N, 1986, CANCER, V58, P903, DOI 10.1002/1097-0142(19860815)58:4<903::AID-CNCR2820580417>3.0.CO;2-J
  5. Boschi-Pinto C, 2000, J INFECT DIS, V181, P35, DOI 10.1086/315177
  6. Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048
  7. Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112
  8. Gomes M, 2014, ADV EXP MED BIOL, V816, P1, DOI 10.1007/978-3-0348-0837-8_1
  9. Hirata Munetsugu, 2019, Asian Pac J Cancer Prev, V20, P1909, DOI 10.31557/APJCP.2019.20.6.1909
  10. Hirata T, 2007, J GASTROEN HEPATOL, V22, P2238, DOI 10.1111/j.1440-1746.2006.04740.x
  11. INOUE J, 1986, EMBO J, V5, P2883, DOI 10.1002/j.1460-2075.1986.tb04583.x
  12. Isomoto H, 1999, EUR J GASTROEN HEPAT, V11, P497, DOI 10.1097/00042737-199905000-00006
  13. Kozuru M, 1996, CANCER, V78, P1119, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1119::AID-CNCR24>3.0.CO;2-4
  14. Mao YS, 2016, SURG ONCOL CLIN N AM, V25, P439, DOI 10.1016/j.soc.2016.02.001
  15. Matsumoto S, 2008, J INFECT DIS, V198, P10, DOI 10.1086/588733
  16. MATSUZAKI H, 1990, CANCER, V66, P1763, DOI 10.1002/1097-0142(19901015)66:8<1763::AID-CNCR2820660821>3.0.CO;2-A
  17. MIYAZAKI K, 1991, OBSTET GYNECOL, V77, P107
  18. MURAGUCHI A, 1985, J EXP MED, V161, P181, DOI 10.1084/jem.161.1.181
  19. Nomori H, 2011, ANN THORAC CARDIOVAS, V17, P19, DOI 10.5761/atcs.oa.09.01529
  20. STRICKLER HD, 1995, INT J CANCER, V61, P23, DOI 10.1002/ijc.2910610105
  21. Stuver SO, 1996, INT J CANCER, V67, P35, DOI 10.1002/(SICI)1097-0215(19960703)67:1<35::AID-IJC8>3.0.CO;2-0
  22. Tahaei SM, ASIAN PAC J CANCER P, V50
  23. Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007
  24. UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
  25. Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
  26. Zane L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-114
  27. Zhang LL, 2017, ACTA PHARMACOL SIN, V38, P1093, DOI 10.1038/aps.2017.17
  28. Zhao TJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020034